Pharmaceutical Industry Trends & News - Pharmaceutical Technology

News

Medicare weight loss drug pilot on ice as insurers decline to contribute

The US Government will now pick up the cost of weight loss drugs offered through the Medicare GLP-1 Bridge scheme until 31 December 2027.

Annabel Kartal Allen

News

MSD teams up with Google Cloud on agentic AI transformation

Salong Debbarma

News

AbbVie opts for North Carolina to house $1.4bn manufacturing site

Annabel Kartal Allen

Analyst Comment

Immunotherapy in locally advanced HNSCC: is there still room for new agents?

News

FDA approves MSD’s once-daily HIV combo Idvynso

News

Sanofi receives FDA approval for Tzield in paediatric diabetes

News

MSD-backed Ray locks in $125m to back eye drug pipeline

News

Eli Lilly doubles down on in vivo with $7bn Kelonia buyout

Analysis

Analyst Comment

Beyond GLP-1Rs: emerging targets poised to gain share of obesity market

GlobalData Healthcare

Features

Magazine: Digital twins become the new battleground for CDMOs

Ross Law

Features

The innovators working to make in vivo cell therapy a reality

Frankie Fattorini

Analyst Comment

Emerging therapies bring hope for frail HNSCC patients unfit for standard treatment

GlobalData Healthcare

Themes

Partner Content

Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design

In pharmaceutical and biopharmaceutical manufacturing, there is zero margin for error when it comes to process integrity and operator safety. Among the many variables that must be tightly controlled, pressure...

More themes

Partner Content

CinnaGen Enters EU Market with EMA Approval for Zandoriah®

News

Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer

Partner Content

Huawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential

Analyst Comment

First responders see AI and other advanced tech as essential

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Venous Thromboembolism Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2034

$17995.00

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026: Pre-Conference Coverage

$1500.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

MSD teams up with Google Cloud on agentic AI transformation

AbbVie opts for North Carolina to house $1.4bn manufacturing site

Immunotherapy in locally advanced HNSCC: is there still room for new agents?

FDA approves MSD’s once-daily HIV combo Idvynso

Sanofi receives FDA approval for Tzield in paediatric diabetes

MSD-backed Ray locks in $125m to back eye drug pipeline

Eli Lilly doubles down on in vivo with $7bn Kelonia buyout

Beyond GLP-1Rs: emerging targets poised to gain share of obesity market

Magazine: Digital twins become the new battleground for CDMOs

The innovators working to make in vivo cell therapy a reality

Emerging therapies bring hope for frail HNSCC patients unfit for standard treatment

Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

The Future of Pharma - Looking Ahead to 2026

Venture Capital Investment Trends in Pharma - Q1 2026

Merger & Acquisition Trends in Pharma - Q1 2026

Venous Thromboembolism Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2034

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026: Pre-Conference Coverage

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

The Future of Pharma​ - Looking Ahead to 2026

Venture Capital Investment Trends in Pharma - Q1 2026

Merger & Acquisition Trends in Pharma - Q1 2026

Venous Thromboembolism Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2034

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026: Pre-Conference Coverage

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing

The Future of Pharma - Looking Ahead to 2026